← Back to Search

Behavioral Intervention

High intensity gait training for Stroke

N/A

Waitlist Available

Led By Soo Yeon Sun, PhD

Research Sponsored by Alvernia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke)

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Awards & highlights

Study Summary

This trial aims to see if making physical therapy sessions more vigorous by keeping participants' heart rates at a certain level through walking practice can improve their walking function and mental health. Researchers will also look at how

Who is the study for?

This trial is for individuals who have had a stroke and are experiencing depression. Participants should be able to undergo vigorous walking exercises aimed at improving their gait and balance. The study seeks people willing to attend 20 physical therapy sessions where their heart rate will be elevated.Check my eligibility

What is being tested?

The trial is testing the effectiveness of high-intensity gait training on improving walking function, balance, and mental health in post-stroke patients. It also examines how mental health, social support, and health literacy influence attendance at these sessions.See study design

What are the potential side effects?

While not explicitly mentioned, potential side effects may include muscle soreness, fatigue due to intense exercise, increased heart rate during training, joint discomfort or pain related to physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a stroke.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

10-meter walk test

3-meter backwards walk test

6-minute walk test

+8 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: High intensity gait trainingExperimental Treatment1 Intervention

Participants will receive 20 sessions of vigorous walking practice. These sessions are 2-3 times a week.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Alvernia UniversityLead Sponsor

3 Previous Clinical Trials

136 Total Patients Enrolled

Lehigh Valley Health NetworkUNKNOWN

3 Previous Clinical Trials

8,039 Total Patients Enrolled

Soo Yeon Sun, PhDPrincipal InvestigatorAlvernia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available openings for new participants in this research study?

"As per the details on clinicaltrials.gov, this particular research endeavor is not currently seeking participants. This trial was initially shared on 4/11/2024 and last revised on 4/15/2024. However, it's worth noting that out of the vast array of active trials, there are presently 2431 others welcoming new participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke

Soo Yeon Sun, PT, PhD 2024. "Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06373107.